Cis-Platinum Nephropathy Clinical Trial
Official title:
The Effect of Intravenous Mannitol Plus Saline on the Prevention of Cisplatin-induced Nephrotoxicity: A Randomized, Double-blind, Placebo Controlled Trial
This study include cancer patients who had received chemotherapy that include cisplatin. Patients were randomly assigned to either a mannitol 20 g intravenous single dose after cisplatin or a placebo (saline). The primary outcome was to compare acute kidney injury (AKI), which was defined as increase creatinine 0.3 mg/dl in 48 hours by KDIGO criteria using serum creatinine and 24 hour urine creatinine to calculated.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03161977 -
The Effect of Mannitol on the Serum Potassium During Craniotomy
|
N/A |